Canadian Syncope Risk Score (CSRS) Calculator
Risk assessment
Complete the eligibility screen and select the findings from the index emergency department assessment.
The score estimates serious adverse events within 30 days after ED assessment; it is not a diagnostic test and must not replace clinical judgement.
About the Canadian Syncope Risk Score
The Canadian Syncope Risk Score (CSRS) is a clinical prediction rule designed to estimate the probability of a serious adverse event within 30 days after an emergency department assessment for syncope. It combines clinical history, blood pressure, troponin, ECG findings, and the ED physician's diagnostic impression.
It is intended for patients with true syncope after the initial ED evaluation has not identified a serious underlying condition. It should not be used to reassure clinicians when a serious diagnosis is already apparent.
Score components
| Predictor | Criterion | Points |
|---|---|---|
| Vasovagal predisposition | Warm/crowded place, prolonged standing, fear, emotion, or pain | −1 |
| Heart disease history | Coronary/valvular disease, cardiomyopathy, heart failure, nonsinus rhythm/arrhythmia or implanted device | +1 |
| ED systolic BP | Any reading <90 or >180 mmHg | +2 |
| Troponin | >99th percentile of normal population | +2 |
| QRS axis | <−30° or >100° | +1 |
| QRS duration | >130 ms | +1 |
| QTc | >480 ms | +2 |
| ED diagnosis | Vasovagal syncope / Cardiac syncope | −2 / +2 |
Score-specific estimated risk
The following are shrinkage-adjusted expected probabilities from the original derivation model. Scores of 6 or higher were grouped for reporting in the derivation and validation publications; individual estimates shown here are from the original model.
| Score | Estimated 30-day risk | Risk category |
|---|---|---|
| −3 | 0.4% | Very low |
| −2 | 0.7% | Very low |
| −1 | 1.2% | Low |
| 0 | 1.9% | Low |
| 1 | 3.1% | Medium |
| 2 | 5.1% | Medium |
| 3 | 8.1% | Medium |
| 4 | 12.9% | High |
| 5 | 19.7% | High |
| 6–11 | 28.9%–83.6% | Very high |
Risk categories and observed outcomes in the Canadian validation cohort
| Category | Score | Observed 30-day serious outcomes |
|---|---|---|
| Very low | −3 to −2 | 0.2% |
| Low | −1 to 0 | 0.7% |
| Medium | 1 to 3 | 8.0% |
| High | 4 to 5 | 19.2% |
| Very high | 6 to 11 | 51.3% |
Evidence and references
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.